Isthmus Partners’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.62M Buy
106,029
+4,445
+4% +$418K 0.74% 46
2026
Q1
$12M Buy
101,584
+27,465
+37% +$3.4M 1.26% 34
2025
Q4
$9.33M Buy
74,119
+2,626
+4% +$343K 1.04% 41
2025
Q3
$10.5M Buy
71,493
+1,093
+2% +$165K 2.32% 18
2025
Q2
$11M Buy
70,400
+338
+0.5% +$53.6K 1.28% 38
2025
Q1
$11.5M Buy
70,062
+1,241
+2% +$206K 1.44% 31
2024
Q4
$11.2M Buy
68,821
+173
+0.3% +$30.9K 1.36% 35
2024
Q3
$13.4M Buy
68,648
+760
+1% +$140K 1.59% 26
2024
Q2
$11.8M Buy
67,888
+482
+0.7% +$80.2K 1.39% 32
2024
Q1
$11.4M Buy
67,406
+156
+0.2% +$29.2K 1.29% 36
2023
Q4
$13.3M Buy
67,250
+1,465
+2% +$259K 1.73% 13
2023
Q3
$11.4M Buy
65,785
+46
+0.1% +$8.35K 1.65% 12
2023
Q2
$11.3M Buy
65,739
+170
+0.3% +$29.4K 1.54% 18
2023
Q1
$10.9M Buy
+65,569
New +$10.7M 1.54% 17

Other funds holding ZTS

Isthmus Partners's ZTS Position: Q2 2026 in Review

Isthmus Partners increased its Zoetis (ZTS) stake by 4.4% in Q2 2026, buying an estimated $418K and bringing the position to 106,029 shares worth $7.62M. The position accounts for 0.74% of the portfolio, ranked #46.

Isthmus Partners first reported a position in ZTS in Q1 2023 and has held it in 14 quarters since. The position peaked at $13.4M in Q3 2024. 270 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Isthmus Partners held 106,029 shares of Zoetis worth $7.62M as of Q2 2026.
  • Isthmus Partners bought 4,445 Zoetis shares in Q2 2026, an estimated $418K.
  • Zoetis made up 0.74% of Isthmus Partners's portfolio in Q2 2026, its #46 holding.
  • Isthmus Partners first reported a position in Zoetis in Q1 2023 and has held it in 14 quarters since.
  • Isthmus Partners's Zoetis position peaked at $13.4M in Q3 2024.
  • 270 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Isthmus Partners's 13F filing for Q2 2026, filed 20 Jul 2026.